Lydia Jordan

Principal Investigator CGT Supply Chain • GlaxoSmithKline

Lydia Jordan is a Principal Investigator in CGT Supply Chain at GSK.  She is responsible for implementation, compliance, and management of Cell Therapy Operations in the US and Canada markets for cell and gene therapy clinical trials.   

Her 15+ year career at GSK spans drug discovery, CMC and clinical supply with a focus on innovations and advancement in medicine development.

Also Speaking

Steven B. Miller

Li Ou

Vice President • Genemagic Bio

David Sourdive

Co-Founder and Executive Vice President CMC & Manufacturing • Cellectis

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.